[1]
“Sulindac metabolites inhibit epidermal growth factor receptor activation and expression”, JOC, vol. 4, no. 1, Oct. 2005, Accessed: Mar. 17, 2026. [Online]. Available: https://carcinogenesis.com/index.php/JOC/article/view/262